Commonwealth Equity Services’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56K | Buy |
61,522
+2,814
| +5% | +$2.56K | ﹤0.01% | 4141 |
|
2025
Q1 | $27K | Hold |
58,708
| – | – | ﹤0.01% | 4109 |
|
2024
Q4 | $30K | Buy |
58,708
+10,447
| +22% | +$5.34K | ﹤0.01% | 4019 |
|
2024
Q3 | $44K | Buy |
48,261
+500
| +1% | +$456 | ﹤0.01% | 3948 |
|
2024
Q2 | $48K | Hold |
47,761
| – | – | ﹤0.01% | 3899 |
|
2024
Q1 | $71K | Hold |
47,761
| – | – | ﹤0.01% | 3848 |
|
2023
Q4 | $52K | Sell |
47,761
-6,721
| -12% | -$7.32K | ﹤0.01% | 3753 |
|
2023
Q3 | $64K | Buy |
54,482
+3,000
| +6% | +$3.52K | ﹤0.01% | 3628 |
|
2023
Q2 | $73K | Buy |
51,482
+2,993
| +6% | +$4.24K | ﹤0.01% | 3615 |
|
2023
Q1 | $72 | Sell |
48,489
-500
| -1% | -$1 | ﹤0.01% | 3540 |
|
2022
Q4 | $57K | Buy |
48,989
+5,999
| +14% | +$6.98K | ﹤0.01% | 3503 |
|
2022
Q3 | $48K | Sell |
42,990
-2,500
| -5% | -$2.79K | ﹤0.01% | 3493 |
|
2022
Q2 | $71K | Buy |
45,490
+1
| +0% | +$2 | ﹤0.01% | 3431 |
|
2022
Q1 | $70K | Buy |
45,489
+6,860
| +18% | +$10.6K | ﹤0.01% | 3545 |
|
2021
Q4 | $94K | Sell |
38,629
-5,310
| -12% | -$12.9K | ﹤0.01% | 3464 |
|
2021
Q3 | $110K | Sell |
43,939
-10,400
| -19% | -$26K | ﹤0.01% | 3404 |
|
2021
Q2 | $154K | Buy |
54,339
+6,014
| +12% | +$17K | ﹤0.01% | 3329 |
|
2021
Q1 | $113K | Sell |
48,325
-41,504
| -46% | -$97.1K | ﹤0.01% | 3247 |
|
2020
Q4 | $158K | Sell |
89,829
-1,590
| -2% | -$2.8K | ﹤0.01% | 2980 |
|
2020
Q3 | $85K | Buy |
91,419
+6,000
| +7% | +$5.58K | ﹤0.01% | 2901 |
|
2020
Q2 | $74K | Buy |
85,419
+10,591
| +14% | +$9.18K | ﹤0.01% | 2807 |
|
2020
Q1 | $61K | Buy |
74,828
+7,818
| +12% | +$6.37K | ﹤0.01% | 2653 |
|
2019
Q4 | $59K | Sell |
67,010
-47,348
| -41% | -$41.7K | ﹤0.01% | 2788 |
|
2019
Q3 | $112K | Sell |
114,358
-4,402
| -4% | -$4.31K | ﹤0.01% | 2660 |
|
2019
Q2 | $130K | Buy |
118,760
+3,402
| +3% | +$3.72K | ﹤0.01% | 2600 |
|
2019
Q1 | $151K | Buy |
115,358
+19,363
| +20% | +$25.3K | ﹤0.01% | 2529 |
|
2018
Q4 | $87K | Sell |
95,995
-4,583
| -5% | -$4.15K | ﹤0.01% | 2506 |
|
2018
Q3 | $206K | Buy |
100,578
+7,025
| +8% | +$14.4K | ﹤0.01% | 2480 |
|
2018
Q2 | $169K | Buy |
93,553
+1,143
| +1% | +$2.07K | ﹤0.01% | 2512 |
|
2018
Q1 | $217K | Buy |
92,410
+23,269
| +34% | +$54.6K | ﹤0.01% | 2332 |
|
2017
Q4 | $130K | Buy |
69,141
+457
| +0.7% | +$859 | ﹤0.01% | 2478 |
|
2017
Q3 | $171K | Hold |
68,684
| – | – | ﹤0.01% | 2333 |
|
2017
Q2 | $189K | Buy |
68,684
+42,796
| +165% | +$118K | ﹤0.01% | 2254 |
|
2017
Q1 | $78K | Buy |
25,888
+2,972
| +13% | +$8.96K | ﹤0.01% | 2300 |
|
2016
Q4 | $72K | Buy |
+22,916
| New | +$72K | ﹤0.01% | 2222 |
|
2013
Q4 | – | Sell |
-14,249
| Closed | -$44K | – | 1956 |
|
2013
Q3 | $44K | Sell |
14,249
-2,787
| -16% | -$8.61K | ﹤0.01% | 1811 |
|
2013
Q2 | $54K | Buy |
+17,036
| New | +$54K | ﹤0.01% | 1738 |
|